InterVenn InterVenn is a patient-driven, employee-first organization looking at disease in a radically different manner.

The future of diagnostics isn't simply about detecting disease.It's about understanding disease biology with greater pre...
07/30/2026

The future of diagnostics isn't simply about detecting disease.

It's about understanding disease biology with greater precision.

Emerging technologies, including glycoproteomics, are expanding our ability to characterize complex diseases and provide clinicians with deeper biological insight to support patient care.

At InterVenn, we believe that advancing precision medicine today will help shape a healthier future for patients tomorrow.

Learn more about our science at https://intervenn.com/about

'sHealth

Scientific breakthroughs often begin with a better understanding of biology.As researchers continue to uncover how prote...
07/27/2026

Scientific breakthroughs often begin with a better understanding of biology.

As researchers continue to uncover how proteins and glycans interact during disease progression, new opportunities emerge to develop more informative diagnostic tools.

Innovation isn't simply about finding more biomarkers—it's about discovering the biomarkers that matter most.

We're proud to contribute to this rapidly evolving field as we work toward advancing precision diagnostics for women's health.

Discover the science driving innovation: https://intervenn.com/glycoknow

'sHealth

Healthcare generates an incredible amount of biological data.The challenge isn't collecting more information—it's transl...
07/23/2026

Healthcare generates an incredible amount of biological data.

The challenge isn't collecting more information—it's translating that information into meaningful clinical insight.

Innovative diagnostic technologies are helping transform complex biological data into actionable information that can support physicians as they evaluate patient risk and determine next steps.
At InterVenn, we're committed to advancing this next generation of precision diagnostics through the power of glycoproteomics.

Explore how data can become clinical insight: https://intervenn.com/glycoknow

Every biomarker tells part of the story.The greatest opportunity comes from understanding how multiple biological signal...
07/21/2026

Every biomarker tells part of the story.

The greatest opportunity comes from understanding how multiple biological signals work together to reveal what may be happening beneath the surface.

Glycoproteomics represents an exciting frontier because it combines information from proteins and their glycan modifications, providing a more comprehensive view of disease biology.

Continued innovation in biomarker science has the potential to support more personalized and informed patient care.

Learn how InterVenn is advancing glycoproteomics: https://intervenn.com/why-glycoproteomics

Understanding complex diseases requires looking beyond DNA alone.Genes provide the blueprint, but proteins—and the glyca...
07/15/2026

Understanding complex diseases requires looking beyond DNA alone.

Genes provide the blueprint, but proteins—and the glycan structures attached to them—reflect what is happening in the body in real time.

By studying glycoproteins, researchers can gain deeper insight into disease biology, creating new opportunities to improve risk assessment and clinical decision-making.

At InterVenn, we're helping advance the science of glycoproteomics to better understand diseases that have historically been difficult to characterize.

Learn more about how InterVenn is advancing glycoproteomics and precision medicine: https://intervenn.com/why-glycoproteomics

Precision medicine is evolving — and women’s health deserves to be at the center of that evolution.At InterVenn, we are ...
05/28/2026

Precision medicine is evolving — and women’s health deserves to be at the center of that evolution.

At InterVenn, we are mapping glycoprotein signals that may provide deeper understanding of disease biology and support more personalized clinical insight.

We believe the future of diagnostics is not just detecting disease — but understanding how disease behaves in real time.

Follow InterVenn for updates on women’s health innovation.

Women facing ovarian cancer concerns deserve clearer answers and greater confidence in care decisions.InterVenn’s GlycoK...
05/26/2026

Women facing ovarian cancer concerns deserve clearer answers and greater confidence in care decisions.

InterVenn’s GlycoKnow™ Ovarian is designed to help assess malignancy risk in women with pelvic masses using a blood-based glycoproteomics-powered approach.

Our mission is simple: to provide better insight, reduce uncertainty, and advance precision medicine in women’s health.

GlycoKnow™ Ovarian is intended for use by healthcare professionals as an adjunct to existing clinical assessment tools. For more information on intended use and performance, please visit our website. The test has not been evaluated or approved by the US FDA.

What is glycoproteomics — and why does it matter in women’s health?Proteins carry glycans, complex sugar structures that...
05/21/2026

What is glycoproteomics — and why does it matter in women’s health?

Proteins carry glycans, complex sugar structures that influence how diseases develop and progress. By analyzing these glycan signatures, glycoproteomics provides deeper biological insight than genomics or traditional proteomics alone.

At InterVenn, we believe these signals may unlock a powerful new approach to earlier, more confident clinical insight in women’s health.

Visit InterVenn.com to learn more about glycoproteomics.

Women’s Health Month is a reminder that every woman deserves access to earlier answers, deeper insight, and more confide...
05/19/2026

Women’s Health Month is a reminder that every woman deserves access to earlier answers, deeper insight, and more confident care. At InterVenn, we believe the future of women’s health diagnostics lies beyond traditional approaches — unlocking the biological signals hidden within glycoproteomics.

We are proud to advance precision medicine solutions designed to support clinicians and improve patient journeys in ovarian cancer risk assessment and beyond.

Together, we can help shape a new frontier in women’s health.

Learn more about GlycoKnow™ Ovarian and InterVenn’s work in women’s health diagnostics: https://intervenn.com/glycoknow

Address

Two Tower Place, Fifth Floor
South San Francisco, CA
94080

Alerts

Be the first to know and let us send you an email when InterVenn posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to InterVenn:

Shortcuts

Share